OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$229,000
-100.0%
10,000
+15.4%
0.01%
-50.0%
Q1 2018$642,000,0008,6650.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,195,000$142,432,0006.16%
Casdin Capital, LLC 305,000$36,353,0003.99%
Eventide Asset Management 845,168$100,736,0003.47%
HIGHLINE CAPITAL MANAGEMENT, L.P. 436,000$51,967,0003.26%
NEXTHERA CAPITAL LP 21,270$2,535,0003.08%
Camber Capital Management LP 500,000$59,595,0002.97%
Eversept Partners, LP 83,574$9,961,1852.91%
CADIAN CAPITAL MANAGEMENT, LP 610,546$72,771,0002.84%
RTW INVESTMENTS, LP 338,199$40,310,0002.75%
Cormorant Asset Management, LP 300,000$35,757,0002.42%
View complete list of SAREPTA THERAPEUTICS INC shareholders